ANI Pharmaceuticals Inc — datos financieros trimestrales (NASDAQ:ANIP) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 15.86 M34.99 M75.81 M44.05 M30.37 M 185.22 M Flujo de caja de las actividades de inversión -10.68 M-19.85 M-6.91 M-6.16 M-1.4 M -34.32 M Flujo de caja de las actividades financieras -4.91 M-9.91 M-1.75 M6.34 M-4.64 M -9.94 M Flujo de caja libre 13.38 M15.14 M68.9 M37.89 M28.96 M 150.9 M

Noticias

CGON Stock Up 60.8% in Six Months: Here's What You Need to Know

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

Cook de Ani Pharmaceuticals vende acciones por 38.000 dólares

ANI Pharmaceuticals lanza cápsulas genéricas de carbamazepina

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)

Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties

Is American Well (AMWL) Outperforming Other Medical Stocks This Year?

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure

ANI Pharmaceuticals lanza tabletas genéricas de mononitrato de isosorbida

ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)